These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

179 related articles for article (PubMed ID: 23957782)

  • 1. Alterations in thyroid function among the different polycystic ovary syndrome phenotypes.
    Morgante G; Musacchio MC; Orvieto R; Massaro MG; De Leo V
    Gynecol Endocrinol; 2013 Nov; 29(11):967-9. PubMed ID: 23957782
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Women with polycystic ovary syndrome have intrinsic insulin resistance on euglycaemic-hyperinsulaemic clamp.
    Stepto NK; Cassar S; Joham AE; Hutchison SK; Harrison CL; Goldstein RF; Teede HJ
    Hum Reprod; 2013 Mar; 28(3):777-84. PubMed ID: 23315061
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Metformin decreases thyrotropin in overweight women with polycystic ovarian syndrome and hypothyroidism.
    Morteza Taghavi S; Rokni H; Fatemi S
    Diab Vasc Dis Res; 2011 Jan; 8(1):47-8. PubMed ID: 21262871
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of markers of insulin resistance and circulating androgens between women with polycystic ovary syndrome and women with metabolic syndrome.
    Tziomalos K; Katsikis I; Papadakis E; Kandaraki EA; Macut D; Panidis D
    Hum Reprod; 2013 Mar; 28(3):785-93. PubMed ID: 23315058
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Evaluation of a new association between insulin-sensitizers and α-lipoic acid in obese women affected by PCOS].
    Cappelli V; Di Sabatino A; Musacchio MC; De Leo V
    Minerva Ginecol; 2013 Aug; 65(4):425-33. PubMed ID: 24051942
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Thyroidal effect of metformin treatment in patients with polycystic ovary syndrome.
    Rotondi M; Cappelli C; Magri F; Botta R; Dionisio R; Iacobello C; De Cata P; Nappi RE; Castellano M; Chiovato L
    Clin Endocrinol (Oxf); 2011 Sep; 75(3):378-81. PubMed ID: 21521311
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Insulin resistance, insulin sensitization and inflammation in polycystic ovarian syndrome.
    Dhindsa G; Bhatia R; Dhindsa M; Bhatia V
    J Postgrad Med; 2004; 50(2):140-4. PubMed ID: 15235215
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effect of metformin compared with hypocaloric diet on serum C-reactive protein level and insulin resistance in obese and overweight women with polycystic ovary syndrome.
    Esfahanian F; Zamani MM; Heshmat R; Moini nia F
    J Obstet Gynaecol Res; 2013 Apr; 39(4):806-13. PubMed ID: 23279603
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metformin, an efficacious drug in the treatment of polycystic ovary syndrome].
    Hahn S; Quadbeck B; Elsenbruch S; Gärtner R; Finke R; Mann K; Janssen OE
    Dtsch Med Wochenschr; 2004 May; 129(19):1059-64. PubMed ID: 15136950
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of metformin on serum insulin and anti-Mullerian hormone levels and on hyperandrogenism in patients with polycystic ovary syndrome.
    Nascimento AD; Silva Lara LA; Japur de Sá Rosa-e-Silva AC; Ferriani RA; Reis RM
    Gynecol Endocrinol; 2013 Mar; 29(3):246-9. PubMed ID: 23194004
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Thyroid-stimulating hormone is associated with insulin resistance independently of body mass index and age in women with polycystic ovary syndrome.
    Mueller A; Schöfl C; Dittrich R; Cupisti S; Oppelt PG; Schild RL; Beckmann MW; Häberle L
    Hum Reprod; 2009 Nov; 24(11):2924-30. PubMed ID: 19654109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dietary glycemic index is associated with less favorable anthropometric and metabolic profiles in polycystic ovary syndrome women with different phenotypes.
    Graff SK; Mário FM; Alves BC; Spritzer PM
    Fertil Steril; 2013 Oct; 100(4):1081-8. PubMed ID: 23830153
    [TBL] [Abstract][Full Text] [Related]  

  • 13. High prevalence of chronic thyroiditis in patients with polycystic ovary syndrome.
    Garelli S; Masiero S; Plebani M; Chen S; Furmaniak J; Armanini D; Betterle C
    Eur J Obstet Gynecol Reprod Biol; 2013 Jul; 169(2):248-51. PubMed ID: 23548659
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Is subclinical hypothyroidism contributing dyslipidemia and insulin resistance in women with polycystic ovary syndrome?
    Celik C; Abali R; Tasdemir N; Guzel S; Yuksel A; Aksu E; Yılmaz M
    Gynecol Endocrinol; 2012 Aug; 28(8):615-8. PubMed ID: 22329744
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Age-related differences in the reproductive and metabolic implications of polycystic ovarian syndrome: findings in an obese, United States population.
    Johnstone EB; Davis G; Zane LT; Cedars MI; Huddleston HG
    Gynecol Endocrinol; 2012 Oct; 28(10):819-22. PubMed ID: 22475130
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Plasma adiponectin levels in women with polycystic ovary syndrome: impact of metformin treatment in a case-control study.
    Singh S; Akhtar N; Ahmad J
    Diabetes Metab Syndr; 2012; 6(4):207-11. PubMed ID: 23199540
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Inflammatory cytokines and chemokines, skeletal muscle and polycystic ovary syndrome: effects of pioglitazone and metformin treatment.
    Ciaraldi TP; Aroda V; Mudaliar SR; Henry RR
    Metabolism; 2013 Nov; 62(11):1587-96. PubMed ID: 23958241
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of rosiglitazone and metformin on oxidative stress and homocysteine levels in lean patients with polycystic ovary syndrome.
    Yilmaz M; Bukan N; Ayvaz G; Karakoç A; Törüner F; Cakir N; Arslan M
    Hum Reprod; 2005 Dec; 20(12):3333-40. PubMed ID: 16123091
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Association of metformin and pregnancy in the polycystic ovary syndrome. A report of three cases.
    Seale FG; Robinson RD; Neal GS
    J Reprod Med; 2000 Jun; 45(6):507-10. PubMed ID: 10900588
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The management of insulin resistance in polycystic ovary syndrome.
    Teede HJ; Hutchison SK; Zoungas S
    Trends Endocrinol Metab; 2007 Sep; 18(7):273-9. PubMed ID: 17698366
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.